Medicinal application of long synthetic peptide technology.
Data(s) |
2004
|
---|---|
Resumo |
This review covers the latest developments of long synthetic peptide technology for the rapid identification and development of malaria vaccine candidates and immunological modulators. A brief description of the two most common solid-phase synthetic procedures, together with the latest advances in optimisation of peptide chain assembly and analytical instrumentation, is given, with special attention to non-specialists. Several examples of vaccine candidates developed in the authors' or their collaborators' laboratories are also provided. |
Identificador |
http://serval.unil.ch/?id=serval:BIB_D8A7EF59A754 isbn:1744-7682[electronic] pmid:15461574 doi:10.1517/14712598.4.10.1629 isiid:000224515300008 |
Idioma(s) |
en |
Fonte |
Expert opinion on biological therapy, vol. 4, no. 10, pp. 1629-39 |
Palavras-Chave | #Animals; Antigens, Protozoan; B-Lymphocytes; Bee Venoms; Chemistry, Organic; Clinical Trials as Topic; Epitopes; Humans; Hypersensitivity, Immediate; Malaria Vaccines; Mice; Mice, Inbred BALB C; Peptides; Phospholipases A; Plasmodium falciparum; Plasmodium vivax; Protozoan Proteins; T-Lymphocyte Subsets; Vaccines, Subunit; Vaccines, Synthetic |
Tipo |
info:eu-repo/semantics/review article |